The Use of Stromal Vascular Fraction for Knee Arthrosis
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT06171204, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Ghent
- Trial code
- NCT06171204
- Record updated
- 8 November 2024
- Original description
A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis.Read full original descriptionShow less
Gebruik Van Stromale Vasculaire Fractie Uit Vetweefsel Na Invriezing Voor Knie Arthrose
A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis.
Patients will undergo a single liposuction to obtain the SVF. The SVF will then be isolated and frozen in our laboratory. The SVF will then be injected up to 2 times into the fat pad of the patient's knee.
Inclusion: Legal capacity; Osteochondral lesions; Inflammatory complaints; (Peri)tendinitis or tendinopathies and ligamentous injuries; Impingement complaints; Arthrofibrosis; Anterior knee pain.